Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma

類似資料

• Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
  著者:: Grätz, Victoria, 等
  出版事項: (2019)
• Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report
  著者:: Langan, Ewan A., 等
  出版事項: (2021)
• Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma
  著者:: Jiekun Yang, 等
  出版事項: (2025-09-01)
• PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome
  著者:: Obeid, Joseph M., 等
  出版事項: (2016)
• Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid
  著者:: Sadik, Christian D., 等
  出版事項: (2019)